Bank of New York Mellon
MRNA icon

Bank of New York Mellon’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$44.5M Sell
1,611,959
-306,289
-16% -$8.45M 0.01% 1076
2025
Q1
$54.4M Buy
1,918,248
+34,034
+2% +$965K 0.01% 919
2024
Q4
$78.3M Sell
1,884,214
-253,068
-12% -$10.5M 0.01% 763
2024
Q3
$143M Sell
2,137,282
-133,466
-6% -$8.92M 0.03% 490
2024
Q2
$270M Sell
2,270,748
-35,228
-2% -$4.18M 0.05% 297
2024
Q1
$246M Sell
2,305,976
-53,451
-2% -$5.7M 0.05% 330
2023
Q4
$235M Sell
2,359,427
-63,179
-3% -$6.28M 0.05% 336
2023
Q3
$250M Sell
2,422,606
-30,609
-1% -$3.16M 0.06% 310
2023
Q2
$298M Sell
2,453,215
-100,010
-4% -$12.2M 0.06% 278
2023
Q1
$392M Sell
2,553,225
-71,274
-3% -$10.9M 0.09% 216
2022
Q4
$471M Sell
2,624,499
-46,209
-2% -$8.3M 0.11% 185
2022
Q3
$316M Sell
2,670,708
-71,455
-3% -$8.45M 0.08% 234
2022
Q2
$392M Buy
2,742,163
+93,359
+4% +$13.3M 0.09% 205
2022
Q1
$456M Sell
2,648,804
-71,251
-3% -$12.3M 0.09% 201
2021
Q4
$691M Buy
2,720,055
+2,350
+0.1% +$597K 0.12% 143
2021
Q3
$1.05B Buy
2,717,705
+1,319,143
+94% +$508M 0.2% 92
2021
Q2
$329M Buy
1,398,562
+122,435
+10% +$28.8M 0.06% 272
2021
Q1
$167M Sell
1,276,127
-16,961
-1% -$2.22M 0.03% 464
2020
Q4
$135M Buy
1,293,088
+30,262
+2% +$3.16M 0.03% 520
2020
Q3
$89.3M Buy
1,262,826
+196,693
+18% +$13.9M 0.02% 616
2020
Q2
$68.5M Buy
1,066,133
+416,540
+64% +$26.7M 0.02% 711
2020
Q1
$19.5M Buy
649,593
+66,479
+11% +$1.99M 0.01% 1306
2019
Q4
$11.4M Buy
583,114
+82,269
+16% +$1.61M ﹤0.01% 1897
2019
Q3
$7.97M Buy
500,845
+456,007
+1,017% +$7.26M ﹤0.01% 2046
2019
Q2
$657K Buy
44,838
+14,110
+46% +$207K ﹤0.01% 3464
2019
Q1
$625K Buy
+30,728
New +$625K ﹤0.01% 3436